Wenjun Chen
- Molecular Medicine top 2%
- Pharmaceutical Science top 5%
-
- Pain Mechanisms and Treatments 2
- Voice and Speech Disorders 1
-
- Botulinum Toxin and Related Neurological Disorders 2
-
- Medicinal Plant Pharmacodynamics Research 2
- Pharmacological Effects of Natural Compounds 2
-
- Metabolomics and Mass Spectrometry Studies 1
-
- Cardiovascular Disease and Adiposity 1
-
- Cancer Mechanisms and Therapy 1
- Journals
- Journal of Diabetes Investigation (1 paper)Journal of drug targeting (1 paper)International Journal of Medical Sciences (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Wenjun Chen
12 papers receiving 633 citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Molecular Medicine 283
- Biological Psychiatry 29
- Pharmaceutical Science 57
- Biomaterials 72
- Complementary and alternative medicine 43
Countries citing papers authored by Wenjun Chen
This map shows the geographic impact of Wenjun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjun Chen more than expected).
Fields of papers citing papers by Wenjun Chen
This network shows the impact of papers produced by Wenjun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjun Chen. The network helps show where Wenjun Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenjun Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 62 | |
| 5 | 2021 | 14 | |
| 6 | 2018 | 16 | |
| 7 | 2017 | 10 | |
| 8 | 2017 | 9 | |
| 9 | 2017 | 27 | |
| 10 | 2017 | 29 | |
| 11 | Oral bioavailability of curcumin: problems and advancementsbreakdown → | 2016 | 435 |
| 12 | 2016 | 28 | |
| 13 | Inhibition of janus kinase 2 by compound AG490 suppresses the proliferation of MDA-MB-231 cells via up-regulating SARI (suppressor of AP-1, regulated by IFN). | 2015 | 7 |
| 14 | Three-dimensional conformal radiotherapy in combination with transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma. | 2014 | 12 |
About Wenjun Chen
Wenjun Chen is a scholar working on Pharmacology, Complementary and alternative medicine and Molecular Medicine, having authored 14 papers that have together received 651 indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (2 papers), Botulinum Toxin and Related Neurological Disorders (2 papers), Medicinal Plant Pharmacodynamics Research (2 papers), Pharmacological Effects of Natural Compounds (2 papers), Voice and Speech Disorders (1 paper), Metabolomics and Mass Spectrometry Studies (1 paper), Cardiovascular Disease and Adiposity (1 paper) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Molecular Medicine (283 citations), Biological Psychiatry (29 citations) and Pharmaceutical Science (57 citations). Wenjun Chen has collaborated with scholars based in China and United States. Frequent co-authors include Xueyuan Heng, Guangxi Zhai, Yingjie Zhai, Weidong Liu, Dezhong Sun, Feng Yuan, Miao Guo, Shuli Wang, Xinyi Qi and Fei Yang. Their work appears in journals such as Journal of Diabetes Investigation, Journal of drug targeting, International Journal of Medical Sciences, World Journal of Traditional Chinese Medicine and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.